Paradigm Biocapital Advisors LP Biogen Inc. Transaction History

Paradigm Biocapital Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $28.4 Million - $32.4 Million	110,821 Added 46.41%	349,593 $97.2 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $21.2 Million - $25.8 Million	84,167 Added 54.44%	238,772 $66.1 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $30.1 Million - $41.5 Million	154,605 New	154,605 $41.3 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.